Trump Administration Deploys Abbott BinaxNOW Tests to States

Rapid point-of-care tests will support Governors’ reopening efforts

The Trump Administration today detailed the national distribution plan for the Abbott BinaxNOW Ag Card rapid test to assist Governors’ efforts to continue to safely reopen their states. BinaxNOW is a unique testing option to provide support to K-12 teachers and students, higher education, critical infrastructure, first responders, and other priorities as governors deem fit. The BinaxNOW rapid test – the only U.S. Food and Drug Administration-authorized antigen rapid point-of-care test that does not require an instrument – is easy to use, will produce COVID-19 test results in 15 minutes, and costs $5.

“This distribution of tens of millions of rapid tests is the fruit of President Trump’s effective national testing strategy, which draws on the best of the public and private sectors,” said HHS Secretary Alex Azar. “Coordination among FDA, private test developers, federal public health leaders, and state leadership has allowed us to build the world’s largest and most effective testing system, supplying the right tests for the right circumstances.”

Read more